Bioptik Technology
Bioptik Technology Incorporation engages in the manufacturing, wholesale, and retail of biotechnology and medical equipment in Taiwan and internationally. It offers blood glucose, cholesterol, uric acid, hemoglobin and acid multi-function monitoring systems under the EasyMate, EasySure, and EasyTouch brand name, as well as PeTouch Glucose Monitoring System for Dogs and Cats. The company also prov… Read more
Bioptik Technology (4161) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.038x
Based on the latest financial reports, Bioptik Technology (4161) has a cash flow conversion efficiency ratio of 0.038x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$35.83 Million) by net assets (NT$947.02 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Bioptik Technology - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Bioptik Technology's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Bioptik Technology Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bioptik Technology ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bohae Brewery
KO:000890
|
0.023x |
|
Elixir Energy Limited
PINK:ELXPF
|
-0.049x |
|
SEC
KQ:081180
|
-0.020x |
|
Skillz Platform Inc
NYSE:SKLZ
|
-0.195x |
|
I GRANDI VIAGGI
F:95H
|
N/A |
|
Nuo Therapeutics Inc
OTCQB:AURX
|
-0.318x |
|
Premium Catering (Holdings) Limited
NASDAQ:PC
|
N/A |
|
SEOWONINTECH.Co.Ltd
KQ:093920
|
0.008x |
Annual Cash Flow Conversion Efficiency for Bioptik Technology (2017–2024)
The table below shows the annual cash flow conversion efficiency of Bioptik Technology from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$905.27 Million | NT$158.82 Million | 0.175x | -29.79% |
| 2023-12-31 | NT$824.15 Million | NT$205.95 Million | 0.250x | +225.81% |
| 2022-12-31 | NT$717.83 Million | NT$55.06 Million | 0.077x | +229.45% |
| 2021-12-31 | NT$694.54 Million | NT$-41.15 Million | -0.059x | -763.13% |
| 2020-12-31 | NT$735.66 Million | NT$6.57 Million | 0.009x | -83.27% |
| 2019-12-31 | NT$768.38 Million | NT$41.03 Million | 0.053x | +3.64% |
| 2018-12-31 | NT$811.73 Million | NT$41.83 Million | 0.052x | +314.97% |
| 2017-12-31 | NT$887.42 Million | NT$11.02 Million | 0.012x | -- |